
Vongsavanh Sengdara
Examiner (ID: 14050, Phone: (571)270-5770 , Office: P/2829 )
| Most Active Art Unit | 2829 |
| Art Unit(s) | 4183, 2829, 2826, 2893 |
| Total Applications | 1059 |
| Issued Applications | 665 |
| Pending Applications | 170 |
| Abandoned Applications | 279 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8370181
[patent_doc_number] => 20120219564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'Human Antibodies That Bind Human TNFalpha'
[patent_app_type] => utility
[patent_app_number] => 13/466892
[patent_app_country] => US
[patent_app_date] => 2012-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20857
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466892
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/466892 | Human antibodies that bind human TNFα | May 7, 2012 | Issued |
Array
(
[id] => 8689703
[patent_doc_number] => 08389228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Process for the measurement of the potency of glatiramer acetate'
[patent_app_type] => utility
[patent_app_number] => 13/083112
[patent_app_country] => US
[patent_app_date] => 2011-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15049
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13083112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/083112 | Process for the measurement of the potency of glatiramer acetate | Apr 7, 2011 | Issued |
Array
(
[id] => 5944107
[patent_doc_number] => 20110104727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR FABRY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/966904
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13236
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12966904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966904 | ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR FABRY DISEASE | Dec 12, 2010 | Abandoned |
Array
(
[id] => 6095329
[patent_doc_number] => 20110002935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'ANTIBODY PURIFICATION'
[patent_app_type] => utility
[patent_app_number] => 12/882601
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 64062
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20110002935.pdf
[firstpage_image] =>[orig_patent_app_number] => 12882601
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/882601 | Purified antibody composition | Sep 14, 2010 | Issued |
Array
(
[id] => 6493210
[patent_doc_number] => 20100209409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'METHOD FOR SUPPRESSING IMMUNE SYSTEM RESPONSE TO TRANSPLANTED TISSUE OR CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/773141
[patent_app_country] => US
[patent_app_date] => 2010-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8537
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209409.pdf
[firstpage_image] =>[orig_patent_app_number] => 12773141
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/773141 | Method for suppressing immune system response to transplanted tissue or cells | May 3, 2010 | Issued |
Array
(
[id] => 6520031
[patent_doc_number] => 20100261886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'PROTEIN PURIFICATION BY CITRATE PRECIPITATION'
[patent_app_type] => utility
[patent_app_number] => 12/759016
[patent_app_country] => US
[patent_app_date] => 2010-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8207
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261886.pdf
[firstpage_image] =>[orig_patent_app_number] => 12759016
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/759016 | Protein purification by citrate precipitation | Apr 12, 2010 | Issued |
Array
(
[id] => 6449960
[patent_doc_number] => 20100145029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'ENHANCED CAPACITY AND PURIFICATION OF ANTIBODIES BY MIXED MODE CHROMATOGRAPHY IN THE PRESENCE OF AQUEOUS-SOLUBLE NONIONIC ORGANIC POLYMERS'
[patent_app_type] => utility
[patent_app_number] => 12/709392
[patent_app_country] => US
[patent_app_date] => 2010-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6766
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20100145029.pdf
[firstpage_image] =>[orig_patent_app_number] => 12709392
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/709392 | Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers | Feb 18, 2010 | Issued |
Array
(
[id] => 8283047
[patent_doc_number] => 08217153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Methods and systems for isolating target molecules from complex solutions by column-chromatography using wash solutions containing organic solvents'
[patent_app_type] => utility
[patent_app_number] => 12/693265
[patent_app_country] => US
[patent_app_date] => 2010-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 3741
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12693265
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/693265 | Methods and systems for isolating target molecules from complex solutions by column-chromatography using wash solutions containing organic solvents | Jan 24, 2010 | Issued |
Array
(
[id] => 4547562
[patent_doc_number] => 07820164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Chimeric, human and humanized anti-CSAP monoclonal antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/686011
[patent_app_country] => US
[patent_app_date] => 2010-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 38238
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820164.pdf
[firstpage_image] =>[orig_patent_app_number] => 12686011
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/686011 | Chimeric, human and humanized anti-CSAP monoclonal antibodies | Jan 11, 2010 | Issued |
Array
(
[id] => 6339991
[patent_doc_number] => 20100247535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Chemically Programmable Immunity'
[patent_app_type] => utility
[patent_app_number] => 12/685257
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11398
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247535.pdf
[firstpage_image] =>[orig_patent_app_number] => 12685257
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/685257 | Chemically programmable immunity | Jan 10, 2010 | Issued |
Array
(
[id] => 6289406
[patent_doc_number] => 20100158803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/683538
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15871
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158803.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683538
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683538 | Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies | Jan 6, 2010 | Abandoned |
Array
(
[id] => 4612106
[patent_doc_number] => 07988951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-02
[patent_title] => 'Method for inducing selectively suppressed immune response to transplanted tissue or cells'
[patent_app_type] => utility
[patent_app_number] => 12/627920
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8196
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/988/07988951.pdf
[firstpage_image] =>[orig_patent_app_number] => 12627920
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/627920 | Method for inducing selectively suppressed immune response to transplanted tissue or cells | Nov 29, 2009 | Issued |
Array
(
[id] => 7540564
[patent_doc_number] => 08058407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Purification of acidic proteins using ceramic hydroxyapatite chromatography'
[patent_app_type] => utility
[patent_app_number] => 12/608093
[patent_app_country] => US
[patent_app_date] => 2009-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7600
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12608093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/608093 | Purification of acidic proteins using ceramic hydroxyapatite chromatography | Oct 28, 2009 | Issued |
Array
(
[id] => 4468905
[patent_doc_number] => 07943343
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Production and use of novel peptide-based agents for use with bi-specific antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/582009
[patent_app_country] => US
[patent_app_date] => 2009-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16272
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943343.pdf
[firstpage_image] =>[orig_patent_app_number] => 12582009
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/582009 | Production and use of novel peptide-based agents for use with bi-specific antibodies | Oct 19, 2009 | Issued |
Array
(
[id] => 6467166
[patent_doc_number] => 20100040604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha'
[patent_app_type] => utility
[patent_app_number] => 12/578487
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25666
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040604.pdf
[firstpage_image] =>[orig_patent_app_number] => 12578487
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/578487 | Methods of treating disorders using human antibodies that bind human TNFα | Oct 12, 2009 | Issued |
Array
(
[id] => 6526868
[patent_doc_number] => 20100015055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'PRETREATMENT OF A BIOLOGICAL SAMPLE FROM AN AUTOIMMUNE DISEASE SUBJECT'
[patent_app_type] => utility
[patent_app_number] => 12/550729
[patent_app_country] => US
[patent_app_date] => 2009-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 36084
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015055.pdf
[firstpage_image] =>[orig_patent_app_number] => 12550729
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/550729 | PRETREATMENT OF A BIOLOGICAL SAMPLE FROM AN AUTOIMMUNE DISEASE SUBJECT | Aug 30, 2009 | Abandoned |
Array
(
[id] => 6247285
[patent_doc_number] => 20100136624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method'
[patent_app_type] => utility
[patent_app_number] => 12/462189
[patent_app_country] => US
[patent_app_date] => 2009-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17558
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136624.pdf
[firstpage_image] =>[orig_patent_app_number] => 12462189
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462189 | Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method | Jul 29, 2009 | Abandoned |
Array
(
[id] => 5472965
[patent_doc_number] => 20090246131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/481233
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16200
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246131.pdf
[firstpage_image] =>[orig_patent_app_number] => 12481233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/481233 | Production and use of novel peptide-based agents for use with bi-specific antibodies | Jun 8, 2009 | Issued |
Array
(
[id] => 5398611
[patent_doc_number] => 20090318674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'PROCESS FOR PURIFICATION OF ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/477031
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18225
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12477031
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/477031 | PROCESS FOR PURIFICATION OF ANTIBODIES | Jun 1, 2009 | Abandoned |
Array
(
[id] => 6482040
[patent_doc_number] => 20100008855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/474665
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 40586
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20100008855.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474665
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474665 | Production and use of novel peptide-based agents with bispecific antibodies | May 28, 2009 | Issued |